GluCl.CreON enables selective inhibition of molecularly defined pain circuits. Middleton SJ, Hu H, Perez-Sanchez J, Zuberi S, et al. Pain 2023 Jun 27. doi: 10.1097/j.pain.0000000000002976.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Middleton SJ, Hu H, Perez-Sanchez J, Zuberi S, et al. GluCl.CreON enables selective inhibition of molecularly defined pain circuits. Pain 2023 Jun 27. doi: 10.1097/j.pain.0000000000002976.
PMID: 37366588